CN110872358B - HA-Fc融合蛋白及其制备方法和疫苗 - Google Patents
HA-Fc融合蛋白及其制备方法和疫苗 Download PDFInfo
- Publication number
- CN110872358B CN110872358B CN201911228343.2A CN201911228343A CN110872358B CN 110872358 B CN110872358 B CN 110872358B CN 201911228343 A CN201911228343 A CN 201911228343A CN 110872358 B CN110872358 B CN 110872358B
- Authority
- CN
- China
- Prior art keywords
- fusion protein
- gene
- region
- vaccine
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911228343.2A CN110872358B (zh) | 2019-12-04 | 2019-12-04 | HA-Fc融合蛋白及其制备方法和疫苗 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911228343.2A CN110872358B (zh) | 2019-12-04 | 2019-12-04 | HA-Fc融合蛋白及其制备方法和疫苗 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110872358A CN110872358A (zh) | 2020-03-10 |
CN110872358B true CN110872358B (zh) | 2021-12-10 |
Family
ID=69718253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911228343.2A Active CN110872358B (zh) | 2019-12-04 | 2019-12-04 | HA-Fc融合蛋白及其制备方法和疫苗 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110872358B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007107797A3 (en) * | 2006-03-22 | 2007-11-08 | Immunobiology Ltd | Fusion protein comprising an fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response |
CN106117369A (zh) * | 2016-07-28 | 2016-11-16 | 华中农业大学 | 融合蛋白sHA1‑Fc及应用 |
CN109111508A (zh) * | 2018-09-19 | 2019-01-01 | 天康生物股份有限公司 | 禽流感病毒血凝素抗原及表达其的cho细胞株、制备方法和疫苗 |
CN109134624A (zh) * | 2018-09-19 | 2019-01-04 | 天康生物股份有限公司 | 禽流感病毒血凝素抗原及其制备方法、应用和禽流感疫苗 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109180820B (zh) * | 2018-09-19 | 2021-06-25 | 天康生物制药有限公司 | 马流感病毒h3n8亚型的融合蛋白及其制备方法、应用和疫苗 |
CN110317278B (zh) * | 2019-08-02 | 2021-01-01 | 天康生物(上海)有限公司 | Svv和fmdv的融合蛋白及其编码基因、表达载体、细胞系、工程菌和疫苗与应用 |
-
2019
- 2019-12-04 CN CN201911228343.2A patent/CN110872358B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007107797A3 (en) * | 2006-03-22 | 2007-11-08 | Immunobiology Ltd | Fusion protein comprising an fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response |
CN106117369A (zh) * | 2016-07-28 | 2016-11-16 | 华中农业大学 | 融合蛋白sHA1‑Fc及应用 |
CN109111508A (zh) * | 2018-09-19 | 2019-01-01 | 天康生物股份有限公司 | 禽流感病毒血凝素抗原及表达其的cho细胞株、制备方法和疫苗 |
CN109134624A (zh) * | 2018-09-19 | 2019-01-04 | 天康生物股份有限公司 | 禽流感病毒血凝素抗原及其制备方法、应用和禽流感疫苗 |
Non-Patent Citations (2)
Title |
---|
Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies;Kaverin et al.;《JOURNAL OF VIROLOGY》;20070919;第81卷(第23期);第12911–12917页 * |
Influenza A virus (A/Viet Nam/1203/2004(H5N1)) isolate escape mutant m777/1(4) hemagglutinin gene, complete cds;Kaverin,N.V.et al.;《GenBank》;20071114;第1-2页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110872358A (zh) | 2020-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111234036B (zh) | 非洲猪瘟病毒p72融合蛋白及其制备方法和应用 | |
CN107630024B (zh) | 编码h5亚型禽流感病毒血凝素蛋白的基因及其应用 | |
Singh et al. | Expression of rabies glycoprotein and ricin toxin B chain (RGP–RTB) fusion protein in tomato hairy roots: a step towards Oral vaccination for rabies | |
CN112472801A (zh) | 非洲猪瘟p30、p54、p72和B602L的DNA疫苗和亚单位疫苗及其制备方法与应用 | |
CN107227311B (zh) | 重组猪细小病毒样粒子及其制备方法和应用 | |
CN110981968B (zh) | 含有狂犬病病毒g蛋白的融合蛋白及其制备方法、应用和疫苗 | |
CN103525773A (zh) | 一种提高猪蓝耳病病毒靶细胞感染滴度的方法及其应用 | |
US20220370597A1 (en) | Recombinant protein and vaccine composition of porcine epidemic diarrhea virus | |
JP2011024590A (ja) | 中和エピトープベースの成長増強ワクチン | |
CN109306008A (zh) | 一种猪源性抗猪瘟病毒的单链抗体及其制备方法 | |
CN112142851A (zh) | 一种狂犬病毒表面的亚单位融合蛋白tG及其制备方法和应用 | |
CN111569056B (zh) | 一种猪轮状病毒疫苗、制备该疫苗的抗原及其编码序列 | |
CN110872358B (zh) | HA-Fc融合蛋白及其制备方法和疫苗 | |
CN109207502A (zh) | 猪支原体肺炎和猪圆环病毒2型重组蛋白及制备二联疫苗 | |
CN111454989A (zh) | 一种嵌合型基因i型乙型脑炎病毒病毒样颗粒疫苗及其制备方法和应用 | |
CN112375126B (zh) | 标记猪瘟病毒e2蛋白重组杆状病毒灭活疫苗 | |
CN111662390A (zh) | 禽流感HA-Fd融合蛋白及其制备方法和疫苗 | |
CN110305225B (zh) | Sva-pcv2融合蛋白及其制备方法、基因、生物材料、应用和疫苗 | |
CN108130340A (zh) | 表达鸭源禽流感病毒ns1蛋白的方法以及该方法的应用 | |
CN109207492B (zh) | 一种包含IBV多表位EpiC和NDV F基因的重组基因、重组表达质粒、重组乳酸杆菌及其应用 | |
CN110526959A (zh) | 一种口蹄疫病毒抗原、表达口蹄疫病毒抗原的基因及其重组载体和重组乳酸乳球菌 | |
CN115197961B (zh) | 一种非洲猪瘟病毒b602l重组蛋白稳定表达细胞系及其构建方法和应用 | |
CN115960265B (zh) | 一种长效多价猪口蹄疫和猪瘟疫苗及其制备方法和应用 | |
CN108410785B (zh) | 一种制备细菌菌影的方法 | |
CN114377121B (zh) | 含分子内佐剂的重组非洲猪瘟抗原“鸡尾酒”疫苗及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Applicant after: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. Applicant after: TECON BIOLOGICAL Co.,Ltd. Address before: 2-3 / F, building 8, 338 Galileo Road, Shanghai pilot Free Trade Zone, 201210 Applicant before: Tiankang Biology (Shanghai) Co.,Ltd. Applicant before: TECON BIOLOGICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211115 Address after: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Applicant after: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. Address before: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Applicant before: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. Applicant before: TECON BIOLOGICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Patentee after: Tiankang Pharmaceutical Co.,Ltd. Address before: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Patentee before: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |